What You Should Know: - COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi. - The strategic partnership aims to leverage RWD and artificial intelligence (AI) to accelerate clinical trials specifically focused on multiple myeloma, a cancer affecting white blood cells. The findings from this partnership have the potential to significantly impact future clinical trial designs for multiple myeloma. Unlocking
Read More
Cota Healthcare
COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data
What You Should Know: - COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in funding. - Access to over one million patient data records and additional funding support enhanced real-world data and analytics services in oncology. COTA, Inc., a Boston, MA-based healthcare technology company that uses real-world data to bring clarity to cancer care, today announced it has raised $34 million in Series D funding led by
Read More
Memorial Sloan Kettering, Cota Partner to Advance Personalized Cancer Treatment
In 2011, Cota, a healthcare data and analytics company bridging precision medicine and population health, was founded by doctors for doctors. Over the past six years, the start-up has moved beyond precision medicine as a goal to a reality, and just this past year, have secured a multi-year collaboration with Novartis towards breast cancer and recruited top thought leaders in the space, like former Deputy Chief Health Officer at IBM Watson, Dr. Andrew Norden.Today, Cota announced their latest
Read More
Novartis Selects Cota Healthcare’s Data Analytics Platform to Develop Therapies for Breast Cancer Patients
Novartis Pharmaceuticals Corporation has signed a multi-year agreement with Cota Healthcare, a data and technology platform for value-based precision medicine to help improve clinical and cost outcomes for breast cancer patients. As part of this multi-year agreement, Novartis will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and
Read More
